PubRank

Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer (TIME)

Clinical Trial ID NCT01383148

PubWeight™ 22.79‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01383148

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat Rev Clin Oncol 2013 2.64
2 TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial. Lancet Oncol 2015 1.69
3 Control of the immune response by pro-angiogenic factors. Front Oncol 2014 1.26
4 Molecular pathways and therapeutic targets in lung cancer. Oncotarget 2014 1.16
5 Trial watch: DNA vaccines for cancer therapy. Oncoimmunology 2013 1.11
6 Therapeutic cancer vaccines: past, present, and future. Adv Cancer Res 2013 0.99
7 New modalities of cancer treatment for NSCLC: focus on immunotherapy. Cancer Manag Res 2014 0.94
8 Antigen-specific vaccines for cancer treatment. Hum Vaccin Immunother 2014 0.89
9 Immunotherapy for lung cancer: advances and prospects. Am J Clin Exp Immunol 2016 0.89
10 Immunotherapy in lung cancer. Transl Lung Cancer Res 2014 0.82
11 A new age for vaccine therapy in renal cell carcinoma. Cancer J 2013 0.81
12 Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination. Hum Vaccin Immunother 2014 0.81
13 Gefitinib plus interleukin-2 in advanced non-small cell lung cancer patients previously treated with chemotherapy. Cancers (Basel) 2014 0.81
14 What lies within: novel strategies in immunotherapy for non-small cell lung cancer. Oncologist 2013 0.81
15 Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy. Oncoimmunology 2014 0.80
16 Cellular and molecular immunology of lung cancer: therapeutic implications. Expert Rev Clin Immunol 2014 0.79
17 Re-examination of maintenance therapy in non-small cell lung cancer with the advent of new anti-cancer agents. Drugs 2013 0.78
18 Impact of TG4010 Vaccine on Health-Related Quality of Life in Advanced Non-Small-Cell Lung Cancer: Results of a Phase IIB Clinical Trial. PLoS One 2015 0.77
19 Immunotherapy for non-small cell lung cancer: current concepts and clinical trials. Eur J Cardiothorac Surg 2015 0.77
20 Recent advances in immunotherapy for non-small-cell lung cancer. Hum Vaccin Immunother 2013 0.76
21 Evaluation of tumour vaccine immunotherapy for the treatment of advanced non-small cell lung cancer: a systematic meta-analysis. BMJ Open 2015 0.76
22 Therapeutic vaccines in non-small cell lung cancer. Immunotargets Ther 2013 0.75
23 Therapeutic cancer vaccines and combination immunotherapies involving vaccination. Immunotargets Ther 2014 0.75
24 Challenges and opportunities for cancer vaccines in the current NSCLC clinical scenario. Curr Top Med Chem 2013 0.75
Next 100